Astec Lifesciences reports standalone net loss of Rs 24.45 crore in the September 2025 quarter
Sales decline 25.20% to Rs 73.72 crore
Net Loss of Astec Lifesciences reported to Rs 24.45 crore in the quarter ended September 2025 as against net loss of Rs 38.57 crore during the previous quarter ended September 2024. Sales declined 25.20% to Rs 73.72 crore in the quarter ended September 2025 as against Rs 98.55 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales73.7298.55 -25 OPM %-9.05-20.01 -PBDT-13.99-27.08 48 PBT-24.45-38.57 37 NP-24.45-38.57 37Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content